A Multi-centre, Double-blinded, Placebo-controlled, Randomised, Phase II Clinical Trial for Psilocybin-assisted Therapy for Alcohol Use Disorder

Phase: PHASE2 | Sponsor: University of Sydney | Compound: Psilocybin

Status

planned

Institution

University of Sydney

Start date

2024-09-01

End date

2025-12-01

Registry ID

NCT06444243

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.